Andrew M. Scharenberg

Person

Seattle, WA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Homology directed repair compositions for the treatment of hemoglob...
- Patent number 12,110,499
- Issue date Oct 8, 2024
- Seattle Children's Hospital
- Andrew Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Rapamycin resistant cells
- Patent number 11,987,804
- Issue date May 21, 2024
- Seattle Children's Hospital
- Andrew M. Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Coupling endonucleases with end-processing enzymes drives high effi...
- Patent number 11,959,073
- Issue date Apr 16, 2024
- Seattle Children's Research Institute
- Andrew M. Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Engraftable cell-based immunotherapy for long-term delivery of ther...
- Patent number 11,939,594
- Issue date Mar 26, 2024
- Seattle Children's Hospital
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering allogeneic and immunosuppressive resistant...
- Patent number 11,891,614
- Issue date Feb 6, 2024
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Coupling endonucleases with end-processing enzymes drives high effi...
- Patent number 11,873,479
- Issue date Jan 16, 2024
- Seattle Children's Research Institute
- Andrew M. Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods of exogenous drug activation of chemical-induced signaling...
- Patent number 11,753,460
- Issue date Sep 12, 2023
- Seattle Children's Hospital
- Andrew M. Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Method for treating autoimmune disease using CD4 T-cells with engin...
- Patent number 11,712,454
- Issue date Aug 1, 2023
- Seattle Children's Hospital
- Andrew M. Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Expression of FOXP3 in edited CD34+ cells
- Patent number 11,713,459
- Issue date Aug 1, 2023
- Seattle Children's Hospital
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering allogeneic and immunosuppressive resistant...
- Patent number 11,603,539
- Issue date Mar 14, 2023
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of pre T alpha or functional variant thereof for expanding TCR...
- Patent number 11,414,674
- Issue date Aug 16, 2022
- Cellectis
- Roman Galetto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Long poly(A) plasmids and methods for introduction of long poly(A)...
- Patent number 11,400,169
- Issue date Aug 2, 2022
- Seattle Children's Hospital
- Andrew M. Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering highly active T cell for immunotherapy
- Patent number 11,311,575
- Issue date Apr 26, 2022
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Methods for engineering allogeneic and highly active t cell for imm...
- Patent number 11,304,975
- Issue date Apr 19, 2022
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of pre T alpha or functional variant thereof for expanding TCR...
- Patent number 11,274,316
- Issue date Mar 15, 2022
- Cellectis
- Roman Galetto
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD19 specific chimeric antigen receptor and uses thereof
- Patent number 11,077,144
- Issue date Aug 3, 2021
- Cellectis
- Roman Galetto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coupling endonucleases with end-processing enzymes drives high effi...
- Patent number 11,008,565
- Issue date May 18, 2021
- Seattle Children's Research Institute
- Andrew M. Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD19 specific chimeric antigen receptor and uses thereof
- Patent number 11,007,224
- Issue date May 18, 2021
- Cellectis
- Roman Galetto
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Coupling endonucleases with end-processing enzymes drives high effi...
- Patent number 10,995,332
- Issue date May 4, 2021
- Seattle Children's Research Institute
- Andrew M. Scharenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Coupling endonucleases with end-processing enzymes drives high effi...
- Patent number 10,947,529
- Issue date Mar 16, 2021
- Seattle Children's Research Institute
- Andrew M. Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
CD19 specific chimeric antigen receptor and uses thereof
- Patent number 10,874,693
- Issue date Dec 29, 2020
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Coupling endonucleases with end-processing enzymes drives high effi...
- Patent number 10,745,688
- Issue date Aug 18, 2020
- Seattle Children's Research Institute
- Andrew M. Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Coupling endonucleases with end-processing enzymes drives high effi...
- Patent number 10,745,690
- Issue date Aug 18, 2020
- Seattle Children's Hospital
- Andrew M. Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Coupling endonucleases with end-processing enzymes drives high effi...
- Patent number 10,745,689
- Issue date Aug 18, 2020
- Seattle Children's Research Institute
- Andrew M. Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Enhancing endonuclease based gene editing in primary cells
- Patent number 10,563,226
- Issue date Feb 18, 2020
- Seattle Children's Hospital
- Andrew Scharenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of pre T alpha or functional variant thereof for expanding TCR...
- Patent number 10,517,896
- Issue date Dec 31, 2019
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
CCR5 disruption of cells expressing anti-HIV chimeric antigen recep...
- Patent number 10,494,422
- Issue date Dec 3, 2019
- Seattle Children's Hospital
- Thor Wagner
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Use of preTalpha or functional variant thereof for expanding TCRalp...
- Patent number 10,426,795
- Issue date Oct 1, 2019
- Cellectis
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Compositions and methods comprising the use of cell surface display...
- Patent number 10,407,672
- Issue date Sep 10, 2019
- Seattle Children's Hospital
- Andrew M. Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
RNA based method to obtain stably integrated retroviral vectors
- Patent number 10,378,026
- Issue date Aug 13, 2019
- Cellectis
- Andrew Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Patents Applicationslast 30 patents

Information Patent Application
METHODS FOR ENGINEERING ALLOGENEIC AND IMMUNOSUPPRESSIVE RESISTANT...
- Publication number 20240309397
- Publication date Sep 19, 2024
- CELLECTIS
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RAPAMYCIN RESISTANT CELLS
- Publication number 20240294946
- Publication date Sep 5, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THER...
- Publication number 20240287452
- Publication date Aug 29, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
- Publication number 20240269178
- Publication date Aug 15, 2024
- CELLECTIS
- Roman Ariel GALETTO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LENTIVIRUS FOR GENERATING CELLS EXPRESSING ANTI-CD19 CHIMERIC ANTIG...
- Publication number 20240141375
- Publication date May 2, 2024
- Umoja Biopharma, Inc.
- Andrew SCHARENBERG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
HOMOLOGY DIRECTED REPAIR COMPOSITIONS FOR THE TREATMENT OF HEMOGLOB...
- Publication number 20240124896
- Publication date Apr 18, 2024
- Seattle Children's Hospital (d/b/a Seattle Children's Research Institute)
- Andrew Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RETROVIRAL VECTOR FOR UNIVERAL RECEPTOR THERAPY
- Publication number 20240122978
- Publication date Apr 18, 2024
- Umoja Biopharma, Inc.
- Andrew SCHARENBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS
- Publication number 20240117352
- Publication date Apr 11, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS OF EXOGENOUS DRUG ACTIVATION OF CHEMICAL-INDUCED SIGNALING...
- Publication number 20240117008
- Publication date Apr 11, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
COUPLING ENDONUCLEASES WITH END-PROCESSING ENZYMES DRIVES HIGH EFFI...
- Publication number 20240102001
- Publication date Mar 28, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHOD FOR TREATING AUTOIMMUNE DISEASE USING CD4 T-CELLS WITH ENGIN...
- Publication number 20240033300
- Publication date Feb 1, 2024
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VECTOR SYSTEM FOR DELIVERY OF MULTIPLE POLYNUCLEOTIDES AND USES THE...
- Publication number 20230407330
- Publication date Dec 21, 2023
- Umoja Biopharma, Inc.
- Andrew SCHARENBERG
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
BISPECIFIC TRANSDUCTION ENHANCER
- Publication number 20230348624
- Publication date Nov 2, 2023
- Umoja Biopharma, Inc.
- Andrew SCHARENBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GATED ADAPTER TARGETING RECEPTOR
- Publication number 20230272039
- Publication date Aug 31, 2023
- Umoja Biopharma, Inc.
- Andrew SCHARENBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...
- Publication number 20230201260
- Publication date Jun 29, 2023
- CELLECTIS
- Roman GALETTO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR ENGINEERING HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY
- Publication number 20230056268
- Publication date Feb 23, 2023
- CELLECTIS
- Roman GALETTO
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
LONG POLY(A) PLASMIDS AND METHODS FOR INTRODUCTION OF LONG POLY(A)...
- Publication number 20230054471
- Publication date Feb 23, 2023
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...
- Publication number 20230050345
- Publication date Feb 16, 2023
- CELLECTIS
- Roman GALETTO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR...
- Publication number 20220348955
- Publication date Nov 3, 2022
- CELLECTIS
- Roman Galetto
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR...
- Publication number 20220177914
- Publication date Jun 9, 2022
- CELLECTIS
- Roman Galetto
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MULTICISTRONIC VECTOR FOR SURFACE ENGINEERING LENTIVIRAL PARTICLES
- Publication number 20220017920
- Publication date Jan 20, 2022
- Umoja Biopharma, Inc.
- Andrew SCHARENBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
RAPAMYCIN RESISTANT CELLS
- Publication number 20210340573
- Publication date Nov 4, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HOMOLOGY-DIRECTED REPAIR TEMPLATE DESIGN AND DELIVERY TO EDIT HEMOG...
- Publication number 20210309995
- Publication date Oct 7, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- David J. Rawlings
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COUPLING ENDONUCLEASES WITH END-PROCESSING ENZYMES DRIVES HIGH EFFI...
- Publication number 20210261946
- Publication date Aug 26, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COUPLING ENDONUCLEASES WITH END-PROCESSING ENZYMES DRIVES HIGH EFFI...
- Publication number 20210254043
- Publication date Aug 19, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
EXPRESSION OF HUMAN FOXP3 IN GENE EDITED T CELLS
- Publication number 20210253652
- Publication date Aug 19, 2021
- Seattle Children's Hospital (dba Seattle Children's Research Institute)
- Andrew M. Scharenberg
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR...
- Publication number 20210220405
- Publication date Jul 22, 2021
- CELLECTIS
- Roman Galetto
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HOMOLOGY DIRECTED REPAIR COMPOSITIONS FOR THE TREATMENT OF HEMOGLOB...
- Publication number 20210222201
- Publication date Jul 22, 2021
- Seattie Children's Hospital (dba Seattle Children's Research Institute)
- Andrew Scharenberg
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VIRAL VECTORS AND PACKAGING CELL LINES
- Publication number 20210147871
- Publication date May 20, 2021
- Umoja Biopharma, Inc.
- Andrew SCHARENBERG
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF
- Publication number 20210060080
- Publication date Mar 4, 2021
- CELLECTIS
- Roman GALETTO
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Andrew M. Scharenberg

Person

Patents Grantslast 30 patents

Homology directed repair compositions for the treatment of hemoglob...

Rapamycin resistant cells

Coupling endonucleases with end-processing enzymes drives high effi...

Engraftable cell-based immunotherapy for long-term delivery of ther...

Methods for engineering allogeneic and immunosuppressive resistant...

Coupling endonucleases with end-processing enzymes drives high effi...

Methods of exogenous drug activation of chemical-induced signaling...

Method for treating autoimmune disease using CD4 T-cells with engin...

Expression of FOXP3 in edited CD34+ cells

Methods for engineering allogeneic and immunosuppressive resistant...

Use of pre T alpha or functional variant thereof for expanding TCR...

Long poly(A) plasmids and methods for introduction of long poly(A)...

Methods for engineering highly active T cell for immunotherapy

Methods for engineering allogeneic and highly active t cell for imm...

Use of pre T alpha or functional variant thereof for expanding TCR...

CD19 specific chimeric antigen receptor and uses thereof

Coupling endonucleases with end-processing enzymes drives high effi...

CD19 specific chimeric antigen receptor and uses thereof

Coupling endonucleases with end-processing enzymes drives high effi...

Coupling endonucleases with end-processing enzymes drives high effi...

CD19 specific chimeric antigen receptor and uses thereof

Coupling endonucleases with end-processing enzymes drives high effi...

Coupling endonucleases with end-processing enzymes drives high effi...

Coupling endonucleases with end-processing enzymes drives high effi...

Enhancing endonuclease based gene editing in primary cells

Use of pre T alpha or functional variant thereof for expanding TCR...

CCR5 disruption of cells expressing anti-HIV chimeric antigen recep...

Use of preTalpha or functional variant thereof for expanding TCRalp...

Compositions and methods comprising the use of cell surface display...

RNA based method to obtain stably integrated retroviral vectors

Patents Applicationslast 30 patents

METHODS FOR ENGINEERING ALLOGENEIC AND IMMUNOSUPPRESSIVE RESISTANT...

RAPAMYCIN RESISTANT CELLS

ENGRAFTABLE CELL-BASED IMMUNOTHERAPY FOR LONG-TERM DELIVERY OF THER...

CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF

LENTIVIRUS FOR GENERATING CELLS EXPRESSING ANTI-CD19 CHIMERIC ANTIG...

HOMOLOGY DIRECTED REPAIR COMPOSITIONS FOR THE TREATMENT OF HEMOGLOB...

RETROVIRAL VECTOR FOR UNIVERAL RECEPTOR THERAPY

EXPRESSION OF FOXP3 IN EDITED CD34+ CELLS

METHODS OF EXOGENOUS DRUG ACTIVATION OF CHEMICAL-INDUCED SIGNALING...

COUPLING ENDONUCLEASES WITH END-PROCESSING ENZYMES DRIVES HIGH EFFI...

METHOD FOR TREATING AUTOIMMUNE DISEASE USING CD4 T-CELLS WITH ENGIN...

VECTOR SYSTEM FOR DELIVERY OF MULTIPLE POLYNUCLEOTIDES AND USES THE...

BISPECIFIC TRANSDUCTION ENHANCER

GATED ADAPTER TARGETING RECEPTOR

METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...

METHODS FOR ENGINEERING HIGHLY ACTIVE T CELL FOR IMMUNOTHERAPHY

LONG POLY(A) PLASMIDS AND METHODS FOR INTRODUCTION OF LONG POLY(A)...

METHODS FOR ENGINEERING ALLOGENEIC AND HIGHLY ACTIVE T CELL FOR IMM...

USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR...

USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR...

MULTICISTRONIC VECTOR FOR SURFACE ENGINEERING LENTIVIRAL PARTICLES

RAPAMYCIN RESISTANT CELLS

HOMOLOGY-DIRECTED REPAIR TEMPLATE DESIGN AND DELIVERY TO EDIT HEMOG...

COUPLING ENDONUCLEASES WITH END-PROCESSING ENZYMES DRIVES HIGH EFFI...

COUPLING ENDONUCLEASES WITH END-PROCESSING ENZYMES DRIVES HIGH EFFI...

EXPRESSION OF HUMAN FOXP3 IN GENE EDITED T CELLS

USE OF PRE T ALPHA OR FUNCTIONAL VARIANT THEREOF FOR EXPANDING TCR...

HOMOLOGY DIRECTED REPAIR COMPOSITIONS FOR THE TREATMENT OF HEMOGLOB...

VIRAL VECTORS AND PACKAGING CELL LINES

CD19 SPECIFIC CHIMERIC ANTIGEN RECEPTOR AND USES THEREOF